According to Precedence Research, the global RNA analysis market size is expected to be worth USD 23.39 billion by 2035, increasing from USD 10.21 billion in 2026, with a strong CAGR of 9.65% from ...
Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and ...
The Brighterside of News on MSN
UVA scientists discover possible new treatment for deadliest brain cancer
Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...
Abstract: Prostate cancer is a common type and it ranks second among men. Certain kinds of prostate cancers remain lethargic and don't lead to cancer death, even though lacking treatment. Though, a ...
The success and popularity of GLP-1 receptor agonists (RAs) for the treatment of patients with diabetes and obesity has led to intense interest in other potential effects of treatment, including ...
Every minute, four Americans are told they have cancer and start a journey into one of the most complex diseases in medicine. Now, a new AI tool developed by Microsoft Research and covered today in a ...
The study’s findings track with recent research on the alarming rise of the cancer in younger adults. By Alice Callahan About 15 years ago, Dr. Andrew T. Chan, a gastroenterologist at Mass General ...
The role of postmastectomy chest-wall irradiation in patients with breast cancer classified as pN1 (with involvement of one to three axillary nodes) or pN0 (pathologically node negative) with ...
Drinking tea and coffee could lead to improved cancer outcomes for patients, thanks to the beverages potentially playing a “protective role” against the disease. Specifically, high coffee and/or tea ...
In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...
Amgen's bemarituzumab trial has taken a turn, with a final analysis showing weaker survival benefits than previously found in an earlier pre-specified interim analysis. In June, Amgen and China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results